| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 789,516 | 1,845,947 | 1,990,784 | | Cost of Revenue | 585,421 | 897,254 | 920,949 | | | Gross Profit | 204,095 | 948,693 | 1,069,835 | | | Operating Expenses | | Research Development | 244,244 | 308,121 | 249,970 | | Selling General and Administrative | 327,241 | 411,141 | 338,781 | | Non Recurring | 142,016 |
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (509,407) | 229,432 | 481,084 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (33,918) | 8,373 | 36,545 | | Earnings Before Interest And Taxes | (543,325) | 237,805 | 517,629 | | Interest Expense | 113 | 121 | 136 | | Income Before Tax | (543,438) | 237,683 | 517,493 | | Income Tax Expense | 226,538 | 69,579 | 216,180 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (771,491) | 167,155 | 301,194 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (771,491) | 167,155 | 301,194 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($771,491) | $167,155 | $301,194 |
|
0.18% Nasdaq 
0.42%
Income Statement
